Article info

Original research
Dendritic cell-mediated cross presentation of tumor-derived peptides is biased against plasma membrane proteins

Authors

  • Tim B Fessenden Koch Institute for Integrative Cancer Research at MIT, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Lauren E Stopfer Koch Institute for Integrative Cancer Research at MIT, Massachusetts Institute of Technology, Cambridge, Massachusetts, USADepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Fiona Chatterjee Koch Institute for Integrative Cancer Research at MIT, Massachusetts Institute of Technology, Cambridge, Massachusetts, USADepartment of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Julian Zulueta Koch Institute for Integrative Cancer Research at MIT, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Josh Mesfin Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Therese Cordero Dumit Koch Institute for Integrative Cancer Research at MIT, Massachusetts Institute of Technology, Cambridge, Massachusetts, USADepartment of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, USA PubMed articlesGoogle scholar articles
  • Irene Reijers Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Esmee P Hoefsmit Department of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Christian Blank Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The NetherlandsDepartment of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Forest White Koch Institute for Integrative Cancer Research at MIT, Massachusetts Institute of Technology, Cambridge, Massachusetts, USADepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Stefani Spranger Koch Institute for Integrative Cancer Research at MIT, Massachusetts Institute of Technology, Cambridge, Massachusetts, USADepartment of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USARagon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Stefani Spranger; spranger{at}mit.edu
View Full Text

Citation

Fessenden TB, Stopfer LE, Chatterjee F, et al
Dendritic cell-mediated cross presentation of tumor-derived peptides is biased against plasma membrane proteins

Publication history

  • Accepted April 27, 2022
  • First published July 12, 2022.
Online issue publication 
July 12, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.